Reprint of Classification and pharmacology of progestins
article
OA: closed
CC0
⤵ 19 in-corpus citations
AI-generated summary
This paper reviews the classification and pharmacology of progestins, providing a comprehensive overview of their properties and applications.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Besides the natural progestin, progesterone, there are different classes of progestins, such as retroprogesterone (i.e. dydrogesterone), progesterone derivatives (i.e. medrogestone) 17alpha-hydroxyprogesterone derivatives (i.e. chlormadinone acetate, cyproterone acetate, medroxyprogesterone acetate, megestrol acetate), 19-norprogesterone derivatives (i.e. nomegestrol, promegestone, trimegestone, nesterone), 19-nortestosterone derivatives norethisterone (NET), lynestrenol, levonorgestrel, desogestrel, gestodene, norgestimate, dienogest) and spironolactone derivatives (i.e. drospirenone). Some of the synthetic progestins are prodrugs, which need to be metabolized to become active compounds. Besides the progestogenic effect, which is in common for all progestins, there is a wide range of biological effects, which are different for the various progestins and have to be taken into account, when medical treatment is considered.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Progestins and Antiprogestins in Clinical Practice via openalex
- The new progestagens – advantages and disadvantages via openalex
- doi:10.1210/er.18.4.502 via openalex
- doi:10.1001/jama.280.7.605 via openalex
- doi:10.1001/jama.288.3.321 via openalex
- doi:10.1783/147118902101196685 via openalex
- doi:10.1007/s004440050042 via openalex
- doi:10.1016/s0960-0760(98)00028-4 via openalex
- doi:10.1001/jama.288.1.58 via openalex
- doi:10.1016/s0039-128x(00)00119-7 via openalex
- doi:10.1016/0378-5122(94)00882-8 via openalex
- doi:10.1001/jama.288.1.49 via openalex
- doi:10.1016/s0960-0760(96)00183-5 via openalex
- W2274587683 via openalex
- W2616427682 via openalex
- W6833085864 via openalex
- doi:10.1016/s0140-6736(03)14065-2 via openalex
- doi:10.1097/00042192-200201000-00003 via openalex
- doi:10.3109/09513590009167670 via openalex
- doi:10.1210/edrv.18.4.0308 via openalex
Cited by (18)
- Transforming Endometriosis Care: Interview with Andrew Horne 2025
- Update on the management of endometriosis-associated pain in France 2023
- Hormonal Therapy in Endometriosis and Adenomyosis: Progestins 2022
- Strategies for modelling endometrial diseases 2022
- Dydrogesterone as an Option in the Medical Treatment of Endometriosis: A Brief Comment 2022
- Pharmacological Management of Endometriosis-related Pain: The Expert Opinion 2021
- Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for in vitro Fertilization-A Single-Center Non-inferiority Randomized Controlled Trial 2020
- Modern trends in the treatment of endometriosis 2019
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis 2017
- Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone 2017
- Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive 2016
- Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 2016
- Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review 2015
- Expression of human aldo-keto reductase 1C2 in cell lines of peritoneal endometriosis: Potential implications in metabolism of progesterone and dydrogesterone and inhibition by progestins 2012
- Dienogest (DNG) in der Therapie der Endometriose Übersicht zur aktuellen Studienlage 2011
- The use of newer progestins for contraception 2010
- Hormonal contraceptives and endometriosis/adenomyosis 2010
Source provenance
- openalex
- last seen: 2026-05-11T06:20:36.346967+00:00
License: CC0
· commercial use OK